Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Más filtros

Base de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Am J Pharm Educ ; 84(10): ajpe7884, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-33149326

RESUMEN

Objective. To assess Doctor of Pharmacy (PharmD) students' skills and confidence in using an evidence-based medicine (EBM) approach to answer practice-based, clinical questions. Methods. Pharmacy students' ability to provide evidence-based answers for real-world clinical questions was assessed at two time points in the PharmD curriculum using a standard tool and trained evaluators. Pharmacy students' confidence regarding their EBM skills was self-assessed at four points in the program, with the first survey administered before the EBM sequence and the final survey administered prior to graduation. The survey included five self-assessed skill questions and nine self-confidence questions. Results. Two hundred twenty-four students from two graduating classes were included in the analysis. Over 97% of students received passing scores on their clinical inquiries (mean score=90.4%), confirming their competency in EBM skills. Students' survey responses on all self-assessed skill and confidence questions improved significantly from baseline to graduation. Conclusion. Longitudinal teaching of EBM concepts and opportunities for skills practice developed PharmD students' ability to successfully provide evidence-based answers to authentic clinical questions. This was consistent with students' confidence level and self-assessed skill levels reported on surveys. Future directions include confirming students' use and understanding of EBM concepts after graduation.


Asunto(s)
Educación en Farmacia , Medicina Basada en la Evidencia , Conocimientos, Actitudes y Práctica en Salud , Estudiantes de Farmacia/psicología , Curriculum , Escolaridad , Humanos , Estudios Longitudinales , Autoimagen , Encuestas y Cuestionarios
2.
J Fam Pract ; 66(11): 699-700, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-29099514

RESUMEN

IT IS UNCLEAR, but studies suggest that it should be based largely on individual risk. The American Academy of Pediatric Dentistry recommends a 6-month interval for preventive dental visits (strength of recommendation [SOR]: C, expert opinion), but a 24-month interval does not result in an increased incidence of dental caries in healthy children and young adults or increased incidence of gingivitis in healthy adults (SOR: B, a single randomized controlled trial [RCT]). In adults with risk factors (eg, smoking or diabetes), visits at 6-month intervals are associated with a lower incidence of tooth loss (SOR: C, a retrospective cohort study). Children with risk factors (eg, caries) may benefit from a first dental visit by age 3 years (SOR: C, a retrospective cohort study).


Asunto(s)
Citas y Horarios , Caries Dental/prevención & control , Visita a Consultorio Médico/estadística & datos numéricos , Odontología Preventiva/métodos , Adulto , Niño , Humanos
3.
J Fam Pract ; 66(10): 632-634, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28991943

RESUMEN

Yes, but not as effective as some other methods. Annual pregnancy rates in women using pericoital levonorgestrel 150 mcg to 1 mg range from 4.9% to 8.9%; menstrual irregularity is the most common adverse effect (strength of recommendation [SOR]: B, Cochrane review of lower-quality trials). In women younger than 35 years who have sexual intercourse 6 or fewer times per month, correct and consistent use of pericoital levonorgestrel 1.5 mg results in an annual pregnancy rate of 11% (SOR: B, one large prospective, open-label trial). Pericoital contraception is less effective than long-acting reversible contraceptives (annual pregnancy rates of 0.05%-0.8%) or perfect use of combined oral contraceptives (0.3% annual pregnancy rate), but similar to, or better than, typical use of combined oral contraception (9%) and condoms (18%).


Asunto(s)
Anticonceptivos Orales , Anticonceptivos Poscoito , Anticonceptivos Orales/administración & dosificación , Anticonceptivos Orales/efectos adversos , Anticonceptivos Poscoito/administración & dosificación , Anticonceptivos Poscoito/efectos adversos , Femenino , Humanos , Embarazo , Embarazo no Deseado
5.
J Fam Pract ; 64(9): 584-5, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26546957

RESUMEN

Short-term (<4 months) treatment with opioids provides modest relief of chronic low back pain, but only minimal improvement in function compared with placebo.


Asunto(s)
Analgésicos Opioides/uso terapéutico , Dolor Crónico/tratamiento farmacológico , Dolor de la Región Lumbar/tratamiento farmacológico , Antiinflamatorios no Esteroideos/uso terapéutico , Esquema de Medicación , Humanos , Resultado del Tratamiento
7.
WMJ ; 114(6): 263-9; quiz 270, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26854315

RESUMEN

Infection with the hepatitis C virus (HCV) is a common cause of cirrhosis and liver failure and the most common indication for liver transplant in the United States. Based on the prevalence of HCV infection at 1.3% of the US population, there are an estimated 74,000 people living with HCV infection in the state of Wisconsin, the majority of whom are undiagnosed. HCV infections in Wisconsin have increased, reflecting the increasing use of intravenous heroin in the state. This review discusses up-to-date guidelines for screening, diagnosis, and treatment of HCV. New direct-acting antiviral medications have revolutionized the treatment of HCV with significantly improved outcomes. High cost and limited availability of these medications present challenges in overall management of HCV.


Asunto(s)
Hepatitis C , Antivirales/uso terapéutico , Hepatitis C/diagnóstico , Hepatitis C/epidemiología , Hepatitis C/terapia , Humanos , Trasplante de Hígado , Guías de Práctica Clínica como Asunto , Prevalencia , Estados Unidos/epidemiología , Wisconsin/epidemiología
8.
J Prim Care Community Health ; 4(4): 286-93, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24327665

RESUMEN

PURPOSE: Our primary aim was to characterize the level of medication use across age-groups by examining electronic medical record data for a large number of patients receiving care in primary care clinics. A secondary aim was to identify factors associated with higher levels of medication use or polypharmacy. METHODS: We conducted a retrospective query of electronic medical record data from a clinical data warehouse, evaluating 114 012 patients seen in primary care clinics at least once in the previous 6 months. Medication use was evaluated in 3 different categories: level 1 (0-4 medications), level 2 (5-9 medications), and level 3 (≥ 10 medications). Multivariate analysis was used to analyze different patient demographics and comorbidities for association with level of medication use. RESULTS: At ages 18 to 24 years, 15% (male) to 23% (female) of patients were taking greater than 5 medications, a trend that continued to increase with older cohorts. Female patients were more likely to have level 2 (odds ratio [OR] = 1.76) and level 3 (OR = 2.73) use compared with men. Level 2 and level 3 use was associated with other patient characteristics, including number of patient encounters (level 2 OR = 2.99; level 3 OR = 8.08 for >7 encounters) and common chronic conditions such as chronic pain (level 2 OR = 2.56; level 3 OR = 6.40), diabetes (level 2 OR = 2.4; level 3 OR = 4.61), heart disease (level 2 OR = 1.99; level 3 OR = 3.65), hypertension (level 2 OR = 2.27; level 3 OR = 2.87), and dyslipidemia (level 2 OR = 1.82; level 3 OR = 2.12). CONCLUSION: Electronic medical record data may be an important tool for providing more comprehensive information regarding medication usage. Medication usage assessed by electronic medical records, even among the youngest cohort, appears to be greater than other sources of medication usage indicate. Higher levels of medication use were associated with a number of factors, including gender, body mass index, number of patient encounters, and comorbid conditions.


Asunto(s)
Instituciones de Atención Ambulatoria , Diabetes Mellitus/tratamiento farmacológico , Registros Electrónicos de Salud , Polifarmacia , Atención Primaria de Salud , Adolescente , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Índice de Masa Corporal , Enfermedad Crónica , Comorbilidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Oportunidad Relativa , Estudios Retrospectivos , Factores Sexuales , Adulto Joven
9.
Am J Pharm Educ ; 76(10): 197, 2012 Dec 12.
Artículo en Inglés | MEDLINE | ID: mdl-23275662

RESUMEN

OBJECTIVE: To determine whether longitudinal design and delivery of evidence-based decision making (EBDM) content was effective in increasing students' knowledge, skills, and confidence as they progressed through a doctor of pharmacy (PharmD) curriculum. DESIGN: Three student cohorts were followed from 2005 to 2009 (n=367), as they learned about EBDM through lectures, actively researching case-based questions, and researching and writing answers to therapy-based questions generated in practice settings. ASSESSMENT: Longitudinal evaluations included repeated multiple-choice examinations, confidence surveys, and written answers to practice-based questions (clinical inquiries). Students' knowledge and perception of EBDM principles increased over each of the 3 years. Students' self-efficacy (10-items, p<0.0001) and perceived skills (7-items, p<0.0001) in applying EBDM skills to answer practice-based questions also increased. Graded clinical inquiries verified that students performed satisfactorily in the final 2 years of the program. CONCLUSIONS: This study demonstrated a successful integration of EBDM throughout the curriculum. EBDM can effectively be taught by repetition, use of real examples, and provision of feedback.


Asunto(s)
Curriculum , Toma de Decisiones , Educación en Farmacia/métodos , Aprendizaje , Estudiantes de Farmacia/psicología , Enseñanza/métodos , Competencia Clínica , Evaluación Educacional , Humanos , Conocimiento , Autoeficacia
10.
BMC Health Serv Res ; 8: 144, 2008 Jul 08.
Artículo en Inglés | MEDLINE | ID: mdl-18611245

RESUMEN

BACKGROUND: The purpose of this study was to describe the prevalence of respiratory diseases in older adults and compare the demographic, health and smoking characteristics of those with and without these diseases. Furthermore, we evaluate the association between smoking status and patterns in health care and how concordant this care is with guidelines. METHODS: Using a nationally representative sample of 29,902 older adults who participated in the Medicare Current Beneficiary Survey (1992-2002), we compared guideline recommendations on the treatment and prevention of chronic obstructive pulmonary disease and asthma with survey utilization data, including the use of bronchodilators, spirometry and influenza vaccine. RESULTS: 26% to 30% of older adults were diagnosed with or self-reported chronic respiratory diseases; however 69% received no pharmacological treatment and 30% of patients reporting use of pharmacological treatments did not receive short-acting bronchodilator inhalers. Current smokers appeared to receive significantly less care for respiratory diseases than non-smokers or former smokers. CONCLUSION: Disparities between recommended and actual care for older adults with chronic lung disease require further research. The needs of older adults with co-morbidities and nicotine addiction deserve special attention in care as well as guideline development and implementation.


Asunto(s)
Asma/tratamiento farmacológico , Broncodilatadores/uso terapéutico , Guías de Práctica Clínica como Asunto , Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico , Calidad de la Atención de Salud , Fumar/epidemiología , Anciano , Anciano de 80 o más Años , Asma/diagnóstico , Asma/epidemiología , Revisión de la Utilización de Medicamentos , Femenino , Adhesión a Directriz , Encuestas Epidemiológicas , Humanos , Clasificación Internacional de Enfermedades , Masculino , Medicare/estadística & datos numéricos , Enfermedad Pulmonar Obstructiva Crónica/diagnóstico , Enfermedad Pulmonar Obstructiva Crónica/epidemiología , Estados Unidos/epidemiología
11.
Acad Med ; 83(2): 148-53, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18303359

RESUMEN

Globalization, migration, and widespread health disparities call for interdisciplinary approaches to improve health care at home and abroad. Health professions students are pursuing study abroad in increasing numbers, and universities are responding with programs to address these needs. The University of Wisconsin (UW)-Madison schools of medicine and public health, nursing, pharmacy, veterinary medicine, and the division of international studies have created an interdisciplinary center for global health (CGH). The CGH provides health professions and graduate students with courses, field experiences, and a new Certificate in Global Health. Educational programs have catalyzed a network of enthusiastic UW global health scholars. Partnerships with colleagues in less economically developed countries provide the foundation for education, research, and service programs. Participants have collaborated to improve the education of health professionals and nutrition in Uganda; explore the interplay between culture, community development, and health in Ecuador; improve animal health and address domestic violence in Mexico; and examine successful public health efforts in Thailand. These programs supply students with opportunities to understand the complex determinants of health and structure of health systems, develop adaptability and cross-cultural communication skills, experience learning and working in interdisciplinary teams, and promote equity and reduce health disparities at home and abroad. Based on the principles of equity, sustainability, and reciprocity, the CGH provides a strong foundation to address global health challenges through networking and collaboration among students, staff, and faculty within the UW and beyond.


Asunto(s)
Países en Desarrollo , Educación Profesional/organización & administración , Salud Global , Facultades de Medicina/organización & administración , Ecuador , Educación Médica , Educación Profesional/tendencias , Educación en Salud Pública Profesional , Humanos , Comunicación Interdisciplinaria , México , Facultades de Medicina/tendencias , Tailandia , Uganda , Wisconsin
12.
Am J Health Syst Pharm ; 64(19): 2044-9, 2007 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-17893415

RESUMEN

PURPOSE: The results of a survey conducted to characterize participating practice sites, patient populations, and collaborative physician-pharmacist services provided through an emerging practice-based research network (PBRN) in the primary care setting are presented. METHODS: A targeted sample of faculty pharmacist investigators practicing in primary care settings were selected for participation in this PBRN based on several factors, including past research activities, their interest in soliciting additional clinics within their state to participate in a research network, the potential for regional collaboration, geographic location, and the patient population served. A baseline survey to characterize the PBRN was distributed to members of the PBRN in June 2006. Data were analyzed using descriptive statistics. RESULTS: A total of 81 pharmacists in 48 practice sites were recruited to join the PBRN. Most practice sites were located within family medicine residency programs, and the majority were affiliated with a community hospital or health system. Half of participating practices had 300-599 ambulatory care visits per week. Pharmacists in the PBRN spent their time performing direct patient management and had collaborative practice agreements with physicians. Patient revenue was used to cover pharmacist salaries in about one fifth of the practice sites. Pharmacists in the PBRN reported participation in diverse educational activities, such as point-of-care resident education and curbside consultation in the clinic hallways or their office. CONCLUSION: Eighty-one pharmacists from 48 primary care practice sites in 11 states were recruited to join a PBRN. These pharmacists provided descriptive data regarding their practice site, characteristics of patients served, and clinical services provided as a first step in collaborative research efforts.


Asunto(s)
Investigación Biomédica/organización & administración , Relaciones Interprofesionales , Farmacéuticos , Médicos , Atención Primaria de Salud/organización & administración , Instituciones de Atención Ambulatoria/organización & administración , Humanos , Modelos Organizacionales , Innovación Organizacional , Objetivos Organizacionales , Desarrollo de Programa , Evaluación de Programas y Proyectos de Salud , Encuestas y Cuestionarios , Estados Unidos
13.
Am Fam Physician ; 72(11): 2225-32, 2005 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-16342845

RESUMEN

Although the overall incidence of tuberculosis has been declining in the United States, it remains an important public health concern, particularly among immigrants, homeless persons, and persons infected with human immunodeficiency virus. Patients who present with symptoms of active tuberculosis (e.g., cough, weight loss, or malaise with known exposure to the disease) should be evaluated. Three induced sputum samples for acid-fast bacillus smear and culture should be obtained from patients with findings of tuberculosis or suspicion for active disease. If the patient has manifestations of extrapulmonary tuberculosis, smears and cultures should be obtained from these sites. Most patients with active tuberculosis should be treated initially with isoniazid, rifampin, pyrazinamide, and ethambutol for eight weeks, followed by 18 weeks of treatment with isoniazid and rifampin if needed. Repeat cultures should be performed after the initial eight-week treatment.


Asunto(s)
Antituberculosos/uso terapéutico , Tuberculosis/diagnóstico , Tuberculosis/tratamiento farmacológico , Algoritmos , Humanos , Recurrencia , Factores de Riesgo , Tuberculosis Resistente a Múltiples Medicamentos/terapia , Tuberculosis Pulmonar/complicaciones , Tuberculosis Pulmonar/diagnóstico , Tuberculosis Pulmonar/tratamiento farmacológico
14.
Fam Med ; 37(2): 99-104, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15690249

RESUMEN

Rational drug use has increasingly received public policy attention in efforts to maintain quality health care at lower costs. Prescribing habits are developed during residency training, and education regarding rational drug use should be an integral part of the residency curricula. Considering that many medical errors in family medicine are related to incorrect medication management, there is need for a focused education in pharmacotherapy. This paper outlines suggested guidelines for pharmacotherapy curricula in family medicine residency training, as recommended by the Society of Teachers of Family Medicine Group on Pharmacotherapy. A pharmacotherapy curriculum should include common conditions managed in family medicine, as well as general principles of pharmacotherapy. This should allow for repeated exposure to core topics over a 3-year cycle and be delivered in various settings (didactic teaching, longitudinal active learning, point-of-care education, and rotations). The curriculum should apply and evaluate pharmacotherapy education according to the six core competencies of the Accreditation Council for Graduate Medical Education (ACGME). Although physician faculty can be responsible for pharmacotherapy education, a clinical pharmacist is uniquely qualified to provide this service. Overall, family medicine residents need comprehensive instruction in pharmacotherapy to develop rational prescribing habits. A structured pharmacotherapy curriculum may assist in achieving this goal and in meeting the ACGME core competencies for residency training.


Asunto(s)
Curriculum/normas , Quimioterapia/normas , Medicina Familiar y Comunitaria/educación , Internado y Residencia/normas , Quimioterapia/economía , Humanos , Sociedades Médicas/normas
15.
Pharmacotherapy ; 24(7): 831-7, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15303446

RESUMEN

STUDY OBJECTIVE: To determine the effects of drugs on levels of carbohydrate-deficient transferrin (CDT), using the %CDT test, a new alcohol biomarker, in patients receiving drug therapy for chronic medical conditions such as diabetes mellitus, hypertension, and lipid disorders. DESIGN: Regression analysis of transformed data. SETTING: Eight primary care clinics in central Wisconsin. PATIENTS: Seven hundred ninety-nine primary care patients who were prescribed drug therapy for a variety of chronic illnesses such as diabetes, hypertension, and lipid disorders. MEASUREMENTS AND MAIN RESULTS: The %CDT level, 30-day history of alcohol consumption, symptoms of alcohol abuse or dependence, health status, and prescribed drugs were determined for each patient. All prescribed drugs that were taken by the patients in the last month were determined by self-report, medical records, or pharmacy records. Of the 799 patients, 89 were receiving drug therapy for diabetes, 299 for hypertension, 209 for both diabetes and hypertension, and 202 for medical conditions other than diabetes or hypertension. A regression analysis was performed after the data were transformed. Alcohol consumption, sex, age, tobacco use, and 20 drug classes were entered into the model. Factors associated with increased %CDT levels were alcohol consumption, female sex, and bupropion use. Two additional drug classes, the angiotensin II receptor blockers and the tricyclic antidepressants, were associated with lower %CDT levels. The effects of bupropion and tricyclic antidepressants on %CDT levels, however, appear to be confounded by alcohol intake. CONCLUSION: This study suggests that only one of 20 drug classes-the angiotensin II receptor blockers-affected %CDT levels in our primary care sample. Additional research with larger samples is needed to focus on the effects of individual drugs used in general clinical settings on %CDT levels.


Asunto(s)
Consumo de Bebidas Alcohólicas/sangre , Preparaciones Farmacéuticas/sangre , Transferrina/análogos & derivados , Transferrina/metabolismo , Adulto , Biomarcadores/sangre , Interacciones Farmacológicas , Femenino , Humanos , Análisis de los Mínimos Cuadrados , Masculino , Persona de Mediana Edad , Análisis Multivariante , Análisis de Regresión
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA